BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2019 7:02:25 AM | Browse: 734 | Download: 1184
 |
Received |
|
2019-05-08 04:14 |
|
Peer-Review Started |
|
2019-05-10 02:44 |
|
To Make the First Decision |
|
2019-08-01 00:14 |
|
Return for Revision |
|
2019-08-02 07:13 |
|
Revised |
|
2019-08-09 19:44 |
|
Second Decision |
|
2019-09-12 10:20 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-09-13 15:49 |
|
Articles in Press |
|
2019-09-13 15:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-10-31 05:40 |
|
Publish the Manuscript Online |
|
2019-12-31 07:02 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phani Keerthi Surapaneni, Rachna T Shroff and Vaibhav Sahai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jonathan D Mizrahi, MD, Academic Fellow, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 463, Houston, TX 77030, United States. jdmizrahi@mdanderson.org |
| Key Words |
Biliary tract neoplasms; Fluorouracil; Irinotecan; Cholangiocarcinoma; Retrospective studies; |
| Core Tip |
We retrospectively analysed patients with advanced biliary tract cancers treated with 5-fluorouracil plus irinotecan at three institutions, MD Anderson, University of Michigan and Mayo Clinic in Jacksonville. We identified 98 patients with a median age of 60 years, most of whom (72%) had intrahepatic cholangiocarcinoma. Fifty and 36 patients were treated in the second and third-line settings, respectively. The median progression-free survival and overall survival were 2.4 (95%CI: 1.7-3.1) and 6.6 (95%CI: 4.7-8.4) mo, respectively. |
| Publish Date |
2019-12-31 07:02 |
| Citation |
Mizrahi JD, Gunchick V, Mody K, Xiao L, Surapaneni P, Shroff RT, Sahai V. Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers. World J Gastrointest Oncol 2020; 12(1): 83-91 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i1/83.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i1.83 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
